<img height="1" width="1" src="https://www.facebook.com/tr?id=769125799912420&amp;ev=PageView &amp;noscript=1">
About Our People Legal Stuff Careers
This is an undated photo of sick baby Charlie Gard provided by his family, taken at Great Ormond Street Hospital in London. A British court will assess new evidence Monday July 10, 2017, in the case of 11-month-old Charlie Gard as his mother pleaded with judges to allow the terminally ill infant to receive experimental treatment for his rare genetic disease, mitochondrial depletion syndrome. (Family of Charlie Gard via AP)

Charlie Gard was granted permanent resident status so he can come to the US for treatment



Critically ill British baby Charlie Gard was granted permanent resident status in the U.S. on Tuesday so he can receive experimental treatment for his rare medical illness, The Telegraph reported.

The 11-month-old suffers from a rare genetic disease called mitochondrial DNA depletion syndrome, which weakens the muscles and creates organ dysfunction. The baby has been on life support at a children's hospital in London since October.

The baby was able to obtain resident status after Congress passed an amendment on Tuesday.

Charlie's parents have been fighting in court to keep their son on life support even though some doctors claimed in court that additional treatment was unlikely to work.

Dr. Michio Hirano, a neuroscientist from Columbia University in New York, recently flew to London to examine the baby's condition in a attempt to convince a judge that treatment in the U.S may be effective.

The doctor told the judges that the nucleoside therapy has a 10 percent chance of improving Charlie's condition.

Read Comments
Facebook Twitter Instagram Pinterest Linked In List Menu Enlarge Gallery Info Menu Close Angle Down Angle Up Angle Left Angle Right Grid Grid Play Align Left Search Youtube Mail Mail Angle Down Bookmark